Novel compounds and compositions as cathepsin inhibitors
申请人:Thurairatnam Sukanthini
公开号:US20060189657A1
公开(公告)日:2006-08-24
Novel inhibitors of cathepsin S, K, B, and L, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
NOVEL KETO-OXADIAZOLE DERIVATIVES AS CATHEPSIN INHIBITORS
申请人:Aventis Pharmaceuticals, Inc.
公开号:EP1682524A1
公开(公告)日:2006-07-26
US7482448B2
申请人:——
公开号:US7482448B2
公开(公告)日:2009-01-27
[EN] NOVEL KETO-OXADIAZOLE DERIVATIVES AS CATHEPSIN INHIBITORS<br/>[FR] NOUVEAUX DERIVES DE CETO-OXADIAZOLE COMME INHIBITEURS DE LA CATHEPSINE
申请人:AVENTIS PHARMA INC
公开号:WO2005040142A1
公开(公告)日:2005-05-06
Novel difluorinated amide derivatives of Formula (II) as inhibitors of cathepsin S, K, B, and L, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
Formula (II)的新颖二氟化酰胺衍生物作为猫hepsin S、K、B和L的抑制剂,其药用盐和N-氧化物,它们作为治疗剂的用途以及其制备方法。